Quick Answer
Dogwood Therapeutics, Inc. reported Shares Outstanding of 29.74 million shares for fiscal year 2025.
Dogwood Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 29.74M | +2132.7% |
| 2024 | 1.33M | -95.2% |
| 2024 | 27.76M | +3503.4% |
| 2023 | 770,317 | -95.8% |
| 2022 | 18.33M | +120.0% |
| 2021 | 8.33M | +0.3% |
| 2020 | 8.31M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 2.29M | -91.7% | +20.0% |
| June 30, 2025 | 1.91M | -93.1% | +0.0% |
| March 31, 2025 | 1.91M | -90.1% | +43.5% |
| December 31, 2024 | 1.33M | +72.9% | -95.2% |
| September 30, 2024 | 27.76M | +44.1% | +0.0% |
| June 30, 2024 | 27.76M | +51.4% | +44.1% |
| March 31, 2024 | 19.26M | +5.1% | +2400.0% |
| December 31, 2023 | 770,317 | -95.8% | -96.0% |
- Dogwood Therapeutics, Inc. showed an increase of +2132.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Dogwood Therapeutics, Inc.’s shares outstanding has grown by 258.1% (from 8.31 million shares to 29.74 million shares).
- The most recent figure is from Dogwood Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: